Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-08-15FDA Approved: CARBAMAZEPINE ER — Supplemental Application (Bostal LLC)
FDA approved a supplemental application for Carbamazepine ER submitted by Bostal LLC.
-
FDA approval · 2025-08-15FDA Approved: LAMOTRIGINE — Supplemental Application (Ajanta Pharma USA Inc.)
The FDA approved a supplemental application for lamotrigine from Ajanta Pharma USA Inc. under an ANDA.
-
CLINICAL_TRIALS research · 2025-08-15Clinical Trial Update: Approaches For ThE pRioritization of Patients in priMAry Care Post-COVID To Reduce Health Inequities (AFTERMATH) [NA]
A not-yet-recruiting clinical trial registered on ClinicalTrials.gov, led by Unity Health Toronto. It investigates prioritization of patient…
-
CLINICAL_TRIALS trial_result · 2025-08-14Clinical Trial Update: Transcranial Direct Current Stimulation Therapy for Bipolar Depression [NA]
A completed clinical trial from the University of East London evaluated transcranial direct current stimulation therapy for bipolar depressi…
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: Physical Exercise as Adjunctive Therapy for Affective Disorder and Anxiety
A Region Stockholm-sponsored trial is evaluating physical exercise as an adjunctive treatment for mood and anxiety disorders, with the study…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-08-12FDA Approved: DIVALPROEX SODIUM — Original Application (First Nation Group, LLC)
FDA approved the original ANDA for divalproex sodium from First Nation Group, LLC, authorizing a generic product to be marketed for the same…
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: Individualizing Incentives for Alcohol in the Severely Mentally Ill [NA]
This clinical trial update reports the completion of a study evaluating individualized incentives to address alcohol use in severely mentall…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: Melatonin and Response to Lithium
An ongoing study in Paris is recruiting people with Bipolar I disorder to evaluate whether melatonin affects response to lithium treatment. …
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: A Novel Peer-Delivered Recovery-Focused Suicide Prevention Intervention for Veterans With Serious Mental Illness [NA]
This ClinicalTrials.gov entry describes a novel peer-delivered recovery-focused suicide prevention intervention for veterans with serious me…
-
FDA approval · 2025-08-06FDA Approved: LAMOTRIGINE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
The FDA approved a supplemental application for Lamotrigine from Unichem Pharmaceuticals (USA), Inc., relating to the generic lamotrigine pr…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: Reduction of Anticholinergic Medications Among Persons With Schizophrenia or Other Psychiatric Disorders [NA]
A clinical trial is investigating reduction of anticholinergic medications among persons with schizophrenia or other psychiatric disorders. …
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: Magnetic Resonance-Guided Focused Ultrasound Bilateral Capsulotomy for the Treatment of Refractory Bipolar Depression [NA]
This entry notes an ongoing clinical trial at Sunnybrook Health Sciences Centre evaluating magnetic resonance-guided focused ultrasound bila…
-
CLINICAL_TRIALS trial_result · 2025-08-06Clinical Trial Update: Clonidine to Prevent Delirium After Electroconvulsive Therapy. [Phase 4]
Phase 4 clinical trial evaluating clonidine to prevent delirium after electroconvulsive therapy; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: COMpassion for Psychiatric Disorders And Self-Stigma [NA]
A clinical trial update for the COMpassion for Psychiatric Disorders And Self-Stigma study conducted by University Hospital Strasbourg, curr…
-
CLINICAL_TRIALS trial_result · 2025-08-05Clinical Trial Update: 2-Year Study of Vagus Nerve Stimulation for Higher-Grade Treatment-Resistant Depression: Clinical Outcomes and Policy Recommendation
A two-year study evaluating vagus nerve stimulation for higher-grade treatment-resistant depression reports clinical outcomes and includes a…
-
CLINICAL_TRIALS trial_result · 2025-07-31Clinical Trial Update: Self and Body-esteem in Socio-professional Rehabilitation [NA]
This entry reports the completion of a clinical trial evaluating self- and body-esteem in socio-professional rehabilitation for individuals …
-
FDA approval · 2025-07-30FDA Approved: LOXAPINE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for LOXAPINE by Actavis Pharma, Inc. under ANDA072206, indicating an updated indication or label for…
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: Neurofilament Light Chains and Cognitive Impairment in Chronic Psychiatric Disease [NA]
A recruiting clinical trial led by Hôpital le Vinatier examining neurofilament light chains and cognitive impairment in chronic psychiatric …
-
FDA approval · 2025-07-23FDA Approved: LURASIDONE HYDROCHLORIDE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' supplemental ANDA for Lurasidone hydrochloride, enabling a generic version to be marketed in the U.S. L…
-
CLINICAL_TRIALS research · 2025-07-16Clinical Trial Update: ALTO-100 in Bipolar Disorder With Depression (BD-D) [Phase 2]
ALTO-100 is in Phase 2 and currently recruiting for bipolar disorder with a major depressive episode (BD-D).
-
CLINICAL_TRIALS research · 2025-07-15Clinical Trial Update: Neurofeedback for Bipolar Disorder [NA]
This clinical trial update reports a study evaluating neurofeedback as a treatment for bipolar disorder, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-07-11Clinical Trial Update: A Study of JNJ-55308942 in the Treatment of Bipolar Depression [Phase 2]
A Phase 2 study of JNJ-55308942 for bipolar depression has completed, and results have been posted.
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Exercise and Olanzapine-samidorphan [Phase 4]
A Phase 4 clinical trial is evaluating exercise in combination with olanzapine-samidorphan for schizophrenia and related disorders, includin…
-
FDA approval · 2025-07-08FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for quetiapine fumarate from Aurobindo Pharma Limited to market the generic product for the same ind…
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder [Phase 3]
Phase 3 safety and tolerability trial of lumateperone (Caplyta) in pediatric patients with schizophrenia, bipolar disorder, or autism spectr…